273 related articles for article (PubMed ID: 34280776)
1. Induction of antigen-specific Treg cells in treating autoimmune uveitis via bystander suppressive pathways without compromising anti-tumor immunity.
Chen Z; Zhang T; Kam HT; Qiao D; Jin W; Zhong Y; Zhou M; Zhou H; Chong WP; Chen W; Chen J
EBioMedicine; 2021 Aug; 70():103496. PubMed ID: 34280776
[TBL] [Abstract][Full Text] [Related]
2. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
3. Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.
Hsu SM; Mathew R; Taylor AW; Stein-Streilein J
Clin Exp Immunol; 2014 Apr; 176(1):37-48. PubMed ID: 24266626
[TBL] [Abstract][Full Text] [Related]
4. Interphotoreceptor retinoid binding protein is a potent tolerogen in Lewis rat: suppression of experimental autoimmune uveoretinitis is retinal antigen specific.
Laliotou B; Liversidge J; Forrester JV; Dick AD
Br J Ophthalmol; 1997 Jan; 81(1):61-7. PubMed ID: 9135411
[TBL] [Abstract][Full Text] [Related]
5. Hydrodynamic vaccination with DNA encoding an immunologically privileged retinal antigen protects from autoimmunity through induction of regulatory T cells.
Silver PB; Agarwal RK; Su SB; Suffia I; Grajewski RS; Luger D; Chan CC; Mahdi RM; Nickerson JM; Caspi RR
J Immunol; 2007 Oct; 179(8):5146-58. PubMed ID: 17911600
[TBL] [Abstract][Full Text] [Related]
6. Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen.
Horai R; Silver PB; Chen J; Agarwal RK; Chong WP; Jittayasothorn Y; Mattapallil MJ; Nguyen S; Natarajan K; Villasmil R; Wang P; Karabekian Z; Lytton SD; Chan CC; Caspi RR
J Autoimmun; 2013 Aug; 44():21-33. PubMed ID: 23810578
[TBL] [Abstract][Full Text] [Related]
7. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis.
Liu YH; Mölzer C; Makinen K; Kamoi K; Corbett CLC; Klaska IP; Reid DM; Wilson HM; Kuffová L; Cornall RJ; Forrester JV
Front Immunol; 2020; 11():2071. PubMed ID: 33013877
[TBL] [Abstract][Full Text] [Related]
8. Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis.
Keino H; Takeuchi M; Usui Y; Hattori T; Yamakawa N; Kezuka T; Sakai JI; Usui M
Br J Ophthalmol; 2007 Jan; 91(1):105-10. PubMed ID: 16943228
[TBL] [Abstract][Full Text] [Related]
9. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
10. Following EAU recovery there is an associated MC5r-dependent APC induction of regulatory immunity in the spleen.
Lee DJ; Taylor AW
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8862-7. PubMed ID: 21989727
[TBL] [Abstract][Full Text] [Related]
11. Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity.
Grajewski RS; Silver PB; Agarwal RK; Su SB; Chan CC; Liou GI; Caspi RR
J Exp Med; 2006 Apr; 203(4):851-6. PubMed ID: 16585264
[TBL] [Abstract][Full Text] [Related]
12. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis.
Hara Y; Caspi RR; Wiggert B; Chan CC; Streilein JW
Curr Eye Res; 1992; 11 Suppl():97-100. PubMed ID: 1424755
[TBL] [Abstract][Full Text] [Related]
13. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
14. Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis.
Silver PB; Horai R; Chen J; Jittayasothorn Y; Chan CC; Villasmil R; Kesen MR; Caspi RR
J Immunol; 2015 Apr; 194(7):3011-9. PubMed ID: 25716996
[TBL] [Abstract][Full Text] [Related]
15. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
16. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
17. STAT3-Specific Single Domain Nanobody Inhibits Expansion of Pathogenic Th17 Responses and Suppresses Uveitis in Mice.
Mbanefo EC; Yan M; Kang M; Alhakeem SA; Jittayasothorn Y; Yu CR; Parihar A; Singh S; Egwuagu CE
Front Immunol; 2021; 12():724609. PubMed ID: 34603297
[TBL] [Abstract][Full Text] [Related]
18. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2alpha during inflammatory conditions.
Sugita S; Horie S; Nakamura O; Maruyama K; Takase H; Usui Y; Takeuchi M; Ishidoh K; Koike M; Uchiyama Y; Peters C; Yamamoto Y; Mochizuki M
J Immunol; 2009 Oct; 183(8):5013-22. PubMed ID: 19801522
[TBL] [Abstract][Full Text] [Related]
20. Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses.
Hohki S; Ohguro N; Haruta H; Nakai K; Terabe F; Serada S; Fujimoto M; Nomura S; Kawahata H; Kishimoto T; Naka T
Exp Eye Res; 2010 Aug; 91(2):162-70. PubMed ID: 20420831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
